DK153476A - Fremgangsmade til fremstilling af sterolglykosid - Google Patents

Fremgangsmade til fremstilling af sterolglykosid

Info

Publication number
DK153476A
DK153476A DK153476A DK153476A DK153476A DK 153476 A DK153476 A DK 153476A DK 153476 A DK153476 A DK 153476A DK 153476 A DK153476 A DK 153476A DK 153476 A DK153476 A DK 153476A
Authority
DK
Denmark
Prior art keywords
pyridinyl
pyridinone compounds
carbamyl
intermediates
amino
Prior art date
Application number
DK153476A
Other languages
Danish (da)
English (en)
Inventor
S Inoue
M Kawamata
H Ushimaru
K Nakamichi
Y Takahashi
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of DK153476A publication Critical patent/DK153476A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
DK153476A 1975-04-08 1976-03-31 Fremgangsmade til fremstilling af sterolglykosid DK153476A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50043008A JPS51118817A (en) 1975-04-08 1975-04-08 A process for preparing absorbable steroid glycoside pharmaceutical

Publications (1)

Publication Number Publication Date
DK153476A true DK153476A (da) 1976-10-09

Family

ID=12651949

Family Applications (1)

Application Number Title Priority Date Filing Date
DK153476A DK153476A (da) 1975-04-08 1976-03-31 Fremgangsmade til fremstilling af sterolglykosid

Country Status (11)

Country Link
US (1) US4083969A (sv)
JP (1) JPS51118817A (sv)
AT (1) AT345976B (sv)
BE (1) BE840540A (sv)
DE (1) DE2615336C3 (sv)
DK (1) DK153476A (sv)
FR (1) FR2306702A1 (sv)
GB (1) GB1503402A (sv)
MX (1) MX4258E (sv)
NL (1) NL170494C (sv)
SE (1) SE423966B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2659466A1 (de) * 1976-12-30 1979-02-15 Roecar Holdings Nv Steroline und deren verwendung
DE2759171A1 (de) * 1977-12-31 1979-07-12 Roecar Holdings Nv Arzneimittel mit wirkung als prostaglandinsynthetaseninhibitor
US4254111A (en) * 1978-07-05 1981-03-03 Roecar Holdings (Netherlands Antilles) Nv Sterolin products
US4260603A (en) * 1979-01-02 1981-04-07 Pegel Karl H Sterol glycoside with activity as prostaglandin synthetase inhibitor
US4283394A (en) * 1979-08-06 1981-08-11 Research Corporation Cytotoxic nucleoside-corticosteroid phosphodiesters
JPS56113799A (en) * 1980-02-08 1981-09-07 Nippon Shinyaku Co Ltd Glucoside derivative
JPS57182301A (en) * 1981-01-23 1982-11-10 Wellcome Found Composite body of sugar-containing compound and cycloamlose and manufacture
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
JPH0665648B2 (ja) * 1985-09-25 1994-08-24 塩野義製薬株式会社 白金系抗癌物質の安定な凍結真空乾燥製剤
FR2616068A1 (fr) * 1987-06-04 1988-12-09 Phytland Sa Laboratoires Procede de stabilisation des principes actifs de produits vegetaux et les compositions pharmaceutiques renfermant lesdits principes actifs stabilises
US10125331B2 (en) * 2010-04-29 2018-11-13 Advanced Energy Development Renewable oil refining processes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE35018B1 (en) * 1970-03-18 1975-10-15 Liebenberg R W Therapeutic agent
DE2319873C2 (de) * 1973-04-19 1982-06-16 Boehringer Mannheim Gmbh, 6800 Mannheim 16-O-Alkylderivate von Gitoxigenin-digitoxosiden, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US3881005A (en) * 1973-08-13 1975-04-29 Lilly Co Eli Pharmaceutical dispersible powder of sitosterols and a method for the preparation thereof
US3966918A (en) * 1973-12-12 1976-06-29 Nippon Shinyaku Co., Ltd. Method of preparing aqueous solutions of sterol glycosides and their ester derivatives

Also Published As

Publication number Publication date
SE423966B (sv) 1982-06-21
AT345976B (de) 1978-10-10
NL7603619A (nl) 1976-10-12
US4083969A (en) 1978-04-11
DE2615336A1 (de) 1976-10-21
JPS5523245B2 (sv) 1980-06-21
DE2615336B2 (de) 1979-09-20
ATA243376A (de) 1978-02-15
MX4258E (es) 1982-03-08
DE2615336C3 (de) 1984-08-16
NL170494C (nl) 1983-10-17
GB1503402A (en) 1978-03-08
NL170494B (nl) 1982-06-16
BE840540A (fr) 1976-08-02
FR2306702B1 (sv) 1979-09-21
FR2306702A1 (fr) 1976-11-05
SE7604079L (sv) 1976-10-09
JPS51118817A (en) 1976-10-19

Similar Documents

Publication Publication Date Title
PT65708A (en) Process for the preparation of pyridinyl-2-(1h)-pyridinones
YU40919B (en) Process for preparation of pyridine compounds
GR60052B (en) Preparation process of anti-depressive compounds
JPS51118777A (en) Preparation method of new pyrimidine derivatives
GR62012B (en) Preparation process of heterocyclic amino-alcools
GR59482B (en) Preparation process of novel biphenyloxy-derivatives
DK153476A (da) Fremgangsmade til fremstilling af sterolglykosid
JPS51136672A (en) Preparation method of 33methylpyridine
JPS51113878A (en) Preparation method of new indolylpiperidine
JPS51127083A (en) Preparation method of nicotinic acid amide
IL49985A (en) Preparation of benzyl nitrile derivatives
PT64945B (en) Preparation of therapeutic compounds
GR60822B (en) Preparation process of novel homophthalimides
JPS5239680A (en) Preparation method of nicotinic acid amide
GB1539733A (en) Preparation of 3-phenoxybenzaldehydes
IL49421A0 (en) Process for the preparation of nicotinic acid amide
PT65713A (en) Process for preparation of cycloalkanapyrazole with effect herbicide
GR61816B (en) Preparation process of novel antiferility compounds
IL50150A (en) Preparation of 3-methoxymethyl-cephalosporins
GB2036002B (en) Intermediate for preparation of therapeutically active pyridine compounds
IL52883A (en) Preparation of substituted pyridines
IE43243L (en) Preparation of pantolactone
CS189006B2 (en) Method of preparation of tetrahydro-4-oxo-naftyl-urea compounds
JPS5219680A (en) Preparation method of chlorothianthrene
GB1552499A (en) Intermediates in the preparation of 1314-didehydro - 16 -fluoroprostaglandins

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
PUP Patent expired